Healthcare - Sector
Dicerna Pharmaceuticals's activity chart (see below) currently has 94 price targets and 69 ratings on display.
Analysts' price targets on this stock were met 79.09% of the time, taking 356.54 days on average.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 10-Dec-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2021
$38.25
$28
4 years 11 months 12 days ago
(10-Dec-2021)
2/3 (66.67%)
$0.34 (0.90%)
101
Buy Since 13-May-2020
$38.25
5 years 2 days ago
(20-Nov-2021)
3/3 (100%)
$0.33 (0.87%)
171
Buy Since 13-Sep-2018
$38
5 years 3 days ago
(19-Nov-2021)
9/11 (81.82%)
$-0.03 (-0.08%)
277
Buy Since 12-Mar-2019
$35
$35
5 years 4 days ago
(18-Nov-2021)
4/7 (57.14%)
$-3.03 (-7.97%)
243
Buy Since 06-Nov-2018
$25
5 years 3 months 11 days ago
(11-Aug-2021)
6/10 (60%)
$2.81 (12.66%)
241
What is DRNA (Dicerna Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on DRNA (Dicerna Pharmaceuticals)?
Which analyst has the most public recommendations on DRNA (Dicerna Pharmaceuticals)?
Which analyst is the currently most bullish on DRNA (Dicerna Pharmaceuticals)?
Which analyst is the currently most reserved on DRNA (Dicerna Pharmaceuticals)?